Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06336382 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Tau Biomarkers in Late-onset Psychosis (LOP)

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fieldsv2
  2. Study First Submitted
Hallucinations or delusions that occur for the first time in older people with no acute medical problems or mood symptoms may be related to impending dementia. This study aims to confirm this hypothesis using novel blood biomarkers and Positron Emission Tomography (PET) imaging tracers, as well as non-invasive testing.
Trial Details
NCT Number NCT06336382
Lead Sponsor Jeremy Koppel
Collaborators: National Institute of Mental Health (NIMH)
Conditions
(from sponsor)		 Late Onset Schizophrenia, Delusional Disorder (Late Onset)
Related terms Schizophrenia, Paranoid
Enrollment 16 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov